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' CHAPTER a- GENERAL INTRODUCTION
CHAPTER 1 - GENERAL INTRODUCTION
é1. History
The effects of cardiovascular disease were first 
described in 1669 by Lower in his 'Tractatus de Corde'. 
Subsequently Bonetus in 1679 and 1700 described several 
hundred cases with symptoms and signs which could be 
attributed to lesions of the heart and great vessels 
(White, 1951a). The symptoms and signs of angina pectoris 
were first observed by Heberden in 1768, but he did not 
connect them with coronary artery disease (White, 1951b).
It was not until 1772 and the work of Jenner, a pupil of 
John Hunter, that this connection was discovered (Herrick, 
1942). Indeed the dramatic story of John Hunter's illness, 
and the demonstration at autopsy that the coronary arteries 
of his heart were 'ossified', is a striking example of a 
case of angina pectoris culminating in a final fatal myocardial 
infarction (Willius and Keys, 1941),
However, more than a century was to pass before the 
clinical entity of acute thrombosis with myocardial infarction 
was described by Herrick in his classical paper of 1912. In 
particular, he pointed out that, while the pain of angina 
pectoris is connected with effort and.could be readily
relieved by rest and nitroglycerine, the pain of myocardial 
infarction.was often not associated with effort, and was 
generally more severe and of much longer duration. However, 
it was not until the publication of a paper by McNee in 1925, 
that Herrick's work became widely known in the United Kingdom, 
That myocardial infarction could be detected on the 
electrocardiogram (EGG), was first demonstrated by Parkinson 
and Bedford in 1928,
Since 1920 the incidence of ischaemic heart disease in 
Scotland has vastly increased, as can be seen in Table 1.1.1, 
the data for which was obtained from the 'Annual Report of 
the Registrar General for Scotland', 1968 - Part 1 - Mortality 
Statistics - No. 114, Table Cl - 7,
Table T. 1.1.
Death rates per 100,000 male population from heart 
disease and coronary thrombosis, Scotland, 1920 to 
1968.
CAUSES
Heart disease *
Coronary thrombosis
PERIOD
1920 - 22 
1930 - 32 
1940 - 42 
1950 52
1960 - 62 
1968
1920 - 22 
1930 - 32 
1940 - 42\ 
1950 - 52 
1960 - 62 
1968
DEATHS per 100/000 males
136
195
366
425
451
450
8
21
80
190
281
346
* of all types
1,2. Metabolism of the Normal Heart
The function of the heart is to perform mechanical ■ 
work in the form of muscular contraction. Under normal 
aerobic conditions the metabolism of the myocardium is 
therefore geared to the production of large amounts of 
energy, which takes the form of the high energy compound 
adenosine triphosphate, (ATP). Bing and his colleagues 
(Bing, Siegel, Vitale, Balboni and Sparks, 1953), by means 
of coronary sinus catheterisation, demonstrated that the 
human heart utilises glucose, pyruvate and lactate, (Green 
and Goldberger, 1961). However, the total aerobic metabolism 
of these compounds accounts for only 35% of the oxygen 
consumption of the heart, and it has been established that 
the human heart also uses fatty acids, ketones and amino 
acids (Bing, Siegel, Ungar and Gilbert, 1954). According 
to these authors approximately 3/5ths of thp energy 
expenditure of the heart, in the postabsorptive state, is 
sustained by fatty acids. Further to this, the work of 
Gordon and Cherkes (1956) , and Dole (1956) , proved that the 
principal fraction of plasma concerned with the transport 
of these fatty acids is the plasma nonesterified fatty 
acids, or free fatty acids, (FFA) fraction.
1.3. Metabolism of the Heart after Myocardial Infarction
Direct access to the myocardium in vivo, in man, 
under conditions of ischaemia and infarction is obviously, 
due to practical and ethical reasons, extremely difficult. 
However, in order to investigate the response of the 
myocardium to such conditions, many experiments, using, 
both whole animals and animal tissues, have been carried 
out. From these it is possible to draw some inferences • 
about the metabolism of the infarcted heart.
When an occlusion occurs in the coronary circulation 
that area of the myocardium which the blood vessel supplies 
becomes ischaemic and infarction develops, Bing, Castellanos, 
Grade1, I4upton and Siegel (1956), reported a significant 
decrease in myocardial oxygen extraction after occlusion 
of the coronary arteries of dogs. Due to this lack of 
oxygen the metabolism of this area of the myocardium becomes 
anaerobic.
The energy which can be derived from anaerobic glycolysis 
is approximately 6% of that derived from oxidative 
metabolism (Green and Goldberger, 1961), and Reeves (1959), 
showed, using the turtle heart, that this could only maintain 
cardiac function for a short time. In addition, the muscle's
stores of glycogen rapidly become exhausted, and from 
this point onwards there are no means by which the muscle 
cell can obtain ATP. (Michal, Naegle, Danforth, Ballard 
and Bing, 1959;. Danforth, Naegle and Bing, 1960). During 
ischaemia the uptake of glucose is increased (Brachfeld 1 
and Sch^uer, 1967), and uptake of FFA continues and these 
are then transformed into neutral lipids (Scheuerland 
Brachfêidÿ 1966).
Under normal aerobic conditions the heart extracts 
20 - 40% pf the lactic acid content of arterial blood, 
but lactic acid is produced, either from endogenous 
glycogen or glucose, in the ischaemic myocardium. This 
has been demonstrated on numerous occasions in animal 
experiments (Clark, Gaddie and Stewart, 1932; Shea,
Watson, Piotrowski, Dermksian and Case, 1962) and, more 
recently, in man during angina (Krasnow and Gorlin, 1963;
f
Parker, Chiong, West and Case, 1969) and cardiogenic shock 
(Mueller et al., 1968). The lactic acid so produced 
accumulates in the myocardium and depresses its function 
(Clark et al., 1932; Wildenthal, Mierzwiak, Myers and 
Mitchell, 1968). In experiments on the dog heart in situ, 
GoPdyer, Eckhardt,rOstberg and Goodkind (1961), noted that
the increased concentration of lactic acid causes a 
local fall in pH, and a corresponding disturbance of the 
acid-base balance.
It has been observed in dog and man that, after 
myocardial infarction, a large number of enzymes is 
present in the coronary vein and peripheral venous blood 
(Siegel and Bing, 1956; Konttinen and Halonen, 1963).
Siegel and Bing (1956), showed that, in the dog, changes 
in plasma enzyme activities were associated with pathological 
events which take place many hours after coronary artery 
embolisation, and are correlated with the height of 
coagulation necrosis.
81.4# Outline of Present Investigation
The mechanisms which cause ischaemic heart disease 
and hence myocardial infarction are very much a 
pathological mystery. In the present investigation we 
are not concerned with what these causes are, be they a 
defect in the blood clotting mechanism or in lipid 
metabolism. The purpose of the present study has been 
the simple one of trying to obtain information, by means 
of chemical analysis of the blood of patients with 
suspected myocardial infarction, which would aid the 
clinicians to confirm the diagnosis, assess the severity 
of the lesion, and suggest the likely prognosis.
Two particular questions have been investigated;
1. The usefulness of serum enzyme estimations, and whether 
serial estimations provide more information on which
to base a diagnosis and assess the condition, and 
possible prognosis, of the patient.
2. Whether haemodynamic measurements, blood gas analysis 
and estimations of blood lactate and pyruvate are good 
indices of the degree of severity of the patient's 
condition, and whether these are affected by oxygen 
therapy.
Each of these questions will be discussed in turn.
■ CHAPTER '2' SERUM ENZYMES
CHAPTER :2 - SERUM ENZYMES
2.1. Introduction
Diagnosis of myocardial infarction presents some 
difficulty. Postmortem studies have shown that 25 to 40% of 
acute myocardial infarctions were not so diagnosed (Johnson, 
Achor, Burchell and Edwards, 1959). Until recent years 
diagnosis has been based on the clinical history and the 
EGG results. The ECG however, is fallible (Woods, Laurie 
and Smith, 1963), hence the need for additional diagnostic 
aids such as serum enzyme analysis.
2.1.1. Development of Clinical Enzymology
The use of enzyme assays as an aid to diagnosis dates 
back to 1908 with the introduction by Wohlgemuth of the 
determination of amylase (OC- 1, 4- glucan 4-glucanohydrolas( 
EC 3.2.1.1.) activity in the serum of patients with suspected 
pancreatic disease. Until 1930 this and one other enzyme 
alkaline phosphatase (orthophosphoric monoester phospho- 
hydrolase, EC 3.1.3.1.), which is of value in the diagnosis 
of bone disease (Robison, 1923; Kay, 1929), were the only 
enzymes assayed routinely in clinical laboratories.
The period from 1935 to 1950 however, saw an immense 
increase in the number of enzymes known to biochemists, and
10
a corresponding improvement in the methods of enzyme assay. 
This was largely due to the development of spectrophotometers 
following the use of spectrophotometry by Warburg in 1935 
(Warburg, Christian and Griese, 1935), in the study of 
enzymes responsible for oxidation/reductions involving the 
nicotinamide nucleotide coenzymes. These spectrophotometric 
methods were far easier than the existing manometric ones, 
and for the first time made possible the routine assay of a 
wide range of dehydrogenases, and of the enzymes which could 
be linked to them. This discovery gave a decisive stimulus 
to clinical enzymology, and many enzymes are now routinely
I
used as diagnostic aids (Gowenlock, 1965). A consequence of 
this has been a number of textbooks entirely devoted to 
clinical enzymology (Wilkinson, 1962; King, 1965; Coodley, 
1970a).
2.1.2. Release of Enzymes from Cells
Although we are not, in this work, primarily concerned 
with the mechanisms responsible for the abnormal serum enzyme 
levels found in myocardial infarction, it would seem 
pertinent at this point to discuss these briefly.
The generally held view is that in myocardial infarction 
hypoxic lesion of the muscle causes necrosis, and as a result 
of this there is an increased rafe of release of enzymes from 
the muscle cells. This is supported by the work of Ruegsegger 
Nydickf. F];eiman end LeDue (1959) ^ who failed to detegt any
11
increase in the activity of the enzyme glutamic-oxaloacetic 
*
transaminase, (L aspartate: 2 - oxoglutarate aminotransferase 
EC 2.6.1.1.), (GOT), in the serum of dogs after induction 
of reversible myocardial ischaemia for forty-five minutes 
although in 1955 Agress et al., also using dogs, had detected 
a significant rise in serum GOT, (SGOT), when only 5% of the 
myocardium was necrotic.
Contrary to this Schmidt andSchmidt (1967a),^  observed 
a remarkable increase in enzyme activities in the 
extracellular space within four hours of hypoxic lesion of th< 
isolated perfused rat liver although there was little 
histological or electron microscope evidence of damage (Schmic 
Schmidt, Herfarth, Opitz and Vogell, 1966). This is in 
agreement with the earlier observation of Zierler (1958), thaï 
anoxia caused increased loss of aldolase (ketose - 1 - phosphe 
aldehyde-lyase EC 4.1.2.7.) from the isolated perfused 
peroneus longus muscle of rat and the suggestion by Schmidt ai 
his colleagues, (Schmidt, Schmidt, Horn and Gerlach, 196 3) th< 
changes in cell permeability without cell death may permit es< 
ape of significant amounts of intracellular enzymes. If this : 
so it is possible that in experimental, and clinical myocardial 
infarction other factors, in addition to necrosis, contribute 
to the increased serum enzyme activities. Such a view would
12
explain Wroblewski*s calculation that the lactate dehydrogenase 
(L " lactatç: NAD oxidoreductase. EC 1.1.1.27) content of 
infarcted heart muscle could not maintain, for any length 
of time, the elevated serum LDH, (SLDH), levels commonly found 
after myocardial infarction (Wroblewski, 1963).
1.3. Serum Enzymes after Myocardial Infarction
The discovery that serum enzyme assays were of value 
in the diagnosis of myocardial infarction was made by LaDue’, 
Wroblewski and Karmen (1954). They had observed that the 
serum enzyme activity of GOT was generally elevated after 
. myocardial infarction, and therefore suggested that assays of 
SGOT might be useful in the diagnosis of this condition (LaDue 
et al./ 1954; Karmen, Wroblewski and LaDue, 1955).
These workers then proceeded to look at other enzymes in the 
myocardium.
Amongst those they investigated was LDH which, while by 
no means peculiar to heart muscle is nonetheless abundant 
there (Fig. 2.1.1.), and they did indeed find that, after 
infarction, there was an increase in the activity of SLDH 
(Wroblewski and LaDue, 1955; Wroblewski, Ruegsegger and LaDue 
1956). LDH is widely distributed amongst tissues, (Fig. 2.1.1.) 
and therefore shows elevated activities in serum when any of
Ato
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Fig. 2.1.1.
LDH Activity in Human Organs
147 .145
124
106
50
36
27
a b c d . e f g h  
a - skeletal muscle; b - liver; c - heart; d - kidney; 
e - lymph nodes ; f - pancreas ; g - erythrocytes ; h - lung
from SchmMt gchmMt t t967j3} ,
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these tissues is damaged (Hill and Levi, 1954; Hsieh and 
Blumenthàl, 1956),'and this limits its usefulness in diagnosis,
Many workers have since confirmed these findings for 
GOT (Ostrow, Steinberg, Ticktin, Polis and Evans, 1956;
Chinsky, Shmagranoff and Sherry, 1956), and for LDH 
(Wacker, Ulmer and Vallee, 1956; White, 1956; MacDonald, 
Simpson and Nossal, 1957).
However, in 1960 Dreyfus, Schapira, Resnais and Scebat 
noticed that after myocardial infarction the serum creatine 
phosphokinase (ATP: creatine phosphotransferase. EC 2.7.3.2.), 
(SCPK), showed a transient increase in activity. This enzyme 
was first seen to be of diagnostic significance by Ebashi, 
Toyokura, Momoi and Sugata (1959), who found high SCPK 
activities in patients suffering from muscular dystrophy. 
Unlike GOT and LDH however, this enzyme is not so widely 
distributed amongst the tissues (Fig. 2.1.2.). Elevated 
activities of SCPK are therefore only found after pathological 
damage to myocardial muscle, skeletal muscle and brain tissue, 
and in hypothyroidism (Graig and Ross, 1963). Since it is 
usually possible to exclude the last three of these on the 
grounds .of other clinical evidence, SCPK is therefore the most 
specific enzyme for indicating myocardial necrosis (Sorensen, 
1963; Hess et al., Coodley, 1966).
15
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Fig. 2.1.3. shows the typical enzyme pattern 
exhibited in serum after a myocardial infarction.
The present investigation was based on the idea 
that if frequent serial enzyme estimations were carried 
out information of the sort shown in Fig. 2.1.3. could 
routinely be obtained and could be used to estimate 
the extent of the infarction and the time at which it • 
occurred.
17
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2.2. Results
Thirty three patients were studied. Twenty eight of 
these, all males, were suspected on clinical grounds to have 
had a myocardial infarction. The remaining five, two 
females and three males, were suffering from cardiac disease 
other than myocardial infarction and were either in a state 
of cardiac fibrillation or in tachycardia. These five 
patients were all treated by direct current (DC) countershock.
Although the ideal is to take blood samples at very 
frequent time intervals i.e. two hourly intervals for at 
least the first forty eight hours after infarction, this is 
not in practice feasible. . Therefore the procedure followed
■ r
in these cases was to take blood samples off:
1. As soon as possible after admission.
2. At as near as possible to four or eight hourly intervals 
thereafter, for at least the first forty eight hours.
In some cases the patient died soon after admission, 
in others the patient's condition did not.permit withdrawal 
of frequent blood samples ^ and occasionally samples were found 
to be haemolysed and therefore useless for LDH determinations 
since 1 ml., of completely haemolysed blood has an activity 
approx. one hundred times that of 1 ml,, of serum (Wroblewski 
and LaDUe^> 1955).
19
The enzymes determined were CPK and LDH: CPK was
chosen because of its rapid increase in activity in serum 
within hours of a myocardial infarction, and for its 
specificity; LDH because its activity in serum after 
myocardial infarction rises and falls more slowly than that 
of CPK. It was hoped that the pattern provided by frequent 
estimations of the serum activities of these two enzymes 
together would be a more reliable guide to the time of 
onset, extent of the infarction and the likely prognosis.
Determinations of SCOT were not carried out since the 
pattern of its activity in serum after myocardial infarction 
falls between that of CPK and LDH, (Fig. 2.1.3.), and it did 
not therefore seem likely to give much additional information.
The results for patients with suspected myocardial 
infarction are shown in Figs. 2.2,1. - 2.2,28, and Figs. 
2.2,34. - 2.2,49. inclusive. The results for patients with 
cardiac disease other than myocardial infarction are shown 
in Figs. 2.2.29. - 2.2.33. inclusive.
The order of cases is not chronological,/
20
Units
The unit of enzyme activity was as recommended by the 
International Union of Biochemistry (1964). 
i.e. 'One unit (U) of any enzyme is that amount which
will catalyse the transformation of 1 micromole {ju mole) 
of the substrate per minute under standard conditions*. 
Conditions of Measurement 
Temiperature; CPK was assayed at 30°C
LDH was assayed at 25^C. . ^
21
Figs. 2.2.1. - 2.2.28,
Changes in serum enzyme activities in patients suffering 
from suspected myocardial infarction,
9 Activity of creatine phosphokinase, (CPK), in serum
A Activity of lactate dehydrogenase, (LDH), in serum.
Denotes the time of onset of the infarction process, 
which we took to be onset of seyere, crushing chest pain. .
t Denotes the time of occurrence of a cardiac arrest. 
Time zero on each figure represents 00,01 hours on the day 
of admission.
Note: Previous, history refers to cardiac disease.
' Fig, 2.2.1.
■ Case 1
Age; 52 years 
Previous history; None
History; Severe central chest pain at 10.00 am on day of
admission which persisted till one hour after admission. 
Cardiac arrest at 12.30 pm on day 2.
FCG ihterpretation; Acute antero-lateral myocardial infarction.
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Fig, 2,2.1 
Case 1
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■ Fig, ■2/2.2.
2
Age; 59 years 
Previous history: None
■ History; Intermittent attacks of severe central chest pain, 
nausea and sweating two days prior to admission. 
ECG interpretation: Antero-septal myocardial infarction,'
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• Fig.' 2.2,3 
Case 3 
e; 55 years
Previous history; Myocardial infarction five months previously. 
History; Increasingly severe chest pain on day before admission 
which recurred at 10.00 pm on same day.
ECG interpretation: Posterior myocardial infarction.
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■ Fig. 2.2.4.
‘ Case 4
’ Age; 34 years
■ Previous history; None
■ History: Constricting chest pain at 4.00 am on morning of
admission and subsequently developed ventricular 
fibrillation and at 4.45 pm on same day had a 
cardiac arrest.
ECG interpretation; Antero-lateral myocardial, ischaemia,
but no evidence of myocardial infarction
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Fig. 2.2.4.
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' 'Fig.- 2.2/5.
C s- s e 5
' Age : 47 years
■ Previous history; None 
History; Angina of effort for two weeks. Severe central
chest pain for more than four hours on morning of 
admission.
ECG interpretation: Acute posterior myocardial infarction.
26
1000.
CJ01
g
g
o
.500
Fig. 2.2.5. 
Case 5
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'Fig. 2,-2,6.
Age ; 60 years
Previous history; None
History; Severe chest pain and breathlessness for five days
before admission. On morning of admission chest pain 
became continuous. Died six days after admission.
ECG interpretation: Antero-lateral myocardial infarction.
Post-mortem findings : Extensive areas of infarction involving
left ventricle and almost the whole of the 
septum.
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Fig. 2,2.6
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Fig. 2.2.7.
Case 7
Age; . 63 years .
Previous history; None
History; Angina of effort for seven days before admission.
At midnight on day of admission had sudden onset 
of severe stabbing, then crushing, retrosternal 
chest pain.
ECG interpretation; Acute postero-lateral myocardial infarction,
28
Fig. 2.2p?, 
■ Case 7
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Fig. 2.2.8.
Case 8
*
Age; 65 years
Previous history:- Slight myocardial infarction four years
previously.
History: Choking sensation three days before admission. Severe
chest pain on day before admission and at 4.00 am on 
day of admission breathless, sweating, vomiting and 
further pain.
ECG interpretation: Posterior myocardial ischaemia.
, ■ Fig. 2.2.9.
Case 9
Age; 56 years
Previous history; None
History: At 7.00 pm on day before admission severe retrosternal
chest pain which persisted till admission.
ECG interpretation; Posterior myocardial infarction.
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Fig. 2.2/10.
Case 10
Age; 62 years
Previous history; Myocardial infarction three years previously, 
History; Chest pain for three days prior to admission. On day 
of admission severe chest pain at 10,30 am while 
working and also at rest.
ECG interpretation: Anterior myocardial infarction.
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Fig. 2.2.11.
Case 11
Age; 60 years 
Previous history; None 
■ History; Collapsed with severe chest pain while at work at
10,00 am on morning of admission,
EGG Interpretation; Antero-septal and posterior myocardial
Infarction.
' Fig. 2.2.12.
■ Case 12
Age ; 67 years
Previous history; Angina of effort for several years and myocardla:
Infarction eleven years previously.
History: Severe chest tightness at 6.00 pm on evening before
admission, still persisting when admitted. In left 
ventricular failure on days 2 and 3,
ECG I n t e r p r e t a t i o n ^ . Postero-lateral myocardial Ischaemla.
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Fig. 2.2.13.
Case 13
Age ; 60 years.
Previous history; None
History; Episode of central chest pain two days before
admission which recurred at 3.00 pm and lasted till
10.00 pm on day before admission. At 1.30 am on day 
of admission wakened by severe chest pain lasting two 
hours.
ECG i nterpretat ion: Posterior myocardial infarction.
• Fig. 2.2.14.
■ Case 14
Age : '47 years
Previous history: None
History; Two days before admission experienced sudden onset- of 
severe crushing retrosternal chest pain which lasted 
for about three hours. At 2.00 am on morning of 
admission pain recurred and lasted for two hours. 
Further attacks of severe chest pain on day 3.
ECG interpretation: Day 1 - probable antero-septal myocardial
ischaemla.
Day 2 “ widespread anterior myocardial 
ischaemla.
Day 3 - antero-septal myocardial infarction
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Fig. 2,2.15.
Case 15
Age; 5,8 years *
'Previous history: None
History: At 6.00 am on day previous, to admission experienced
tightness across front of chest which became 
progressively worse and by 6.00 pm was severe.
FCG interpretation: Antero"lateral myocardial infarction.
• Fig. 2.2.16.
Case 16 \
Age; 72 years
Previous history; None
History: Three days before admission had fairly severe chest
pain continuing on and off for two days. No further 
chest .pain on day of admission.
ECG interpretation: Day 1 - evidence of recent posterior
myocardial infarction.
Day 3 - evolving pattern of posterior 
myocardial infarction.
Day 5 " recent posterior myocardial 
infarction.
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Fig. 2.2.17.
Case 17
Age ; 64 years
Previous history; One year previously had a posterior
myocardial infarction.
History; Sudden onset of acute breathlessness, sweating, 
vomiting and chest pain at 1.00 am on day of 
■ admission. On admission unconscious and in left 
ventricular failure. On day 5 was in atrial and 
ventricular fibrillation and had a cardiac arrest.
ECG interpretation; Day 1 - lateral myocardial ischaemla.
Day 5 - atrial and ventricular
fibrillation and lateral 
myocardial ischaemla.
■ Fig.' '2.2.18.
Case 18
Age; 54 years 
Previous history; None
History;. At 10.00 am on morning of admission severe tight 
pain across chest wall which was easing at time 
of admission.
FCG interpretation: Posterior myocardial, infarction.
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Fig. 2.2.19
■ Case 19
Açfe; 34 years ,
Previous history; None
History; Sudden onset of central retrosternal chest pain at 
11.00 pm on evening before admission.
» ECG interpretation; Antero-lateral myocardial infarction.
• Fig.- 2.2.20.
Case 20
45 years 
Pr evious hi s tory: None
History; Angina of effort for several days. Severe chest pain 
P  for three days commencing at 10.00 pm. on evening before
admission. No subsequent pain between then and 
admission.
ECG interpretation; Antero-lateral myocardial infarction.
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Fig. 2.2.21.
Case 21
Age; 68 years*
Previous history; Angina of effort for nine months 
History; At 7.30 pm on day before admission sudden onset 
of central, crushing chest pain.
ECG interpretation; Day 1 - widespread myocardial ischaemla.
Day 3 - recent posterior myocardial 
infarction.
• Fig. 2.2.22.
Case 22.
Age : 67 years
Previous' history; ' Five years previously had a posterior
myocardial infarction.
History ; Dizziness and incipient black-outs.
ECG interpretation: No definite evidence of myocardial
infarction.
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Case 2 3
Age ! 67 years
•previous history; Angina of effort for two to three years. 
History; Severe chest pain at 4.00 am on morning of admission 
and again on day 2. Died'on day 3.
ECG interpretation; Extensive recent deft ventricular
myocardial infarction.
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Fig. '2 ,'2 . 24.
■ Case 24
■ Age: 58 years
Previous history; Angina of effort for six months. 
History: Severe chest discomfort' at 10.00 am on day of
admission. Died on day 2.
ECG interpretation; Incomplete tracing.
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■ Case 25
' Age.: , 40 years
s
■ Previous' hl'sfory s Angina of effort for two years.
■ Historys Severe retrosternal pain at 1.00 pm on day of
admission. Died on day 2.
■ ECG interpretation: Widespread anterior myocardial infarction.
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' Fig'. 2o'2.26.
Case 26
Age: 42 years
Previous history; Six years previously had myocardial
infarction and - has had angina of effort 
since then. \
History; Severe chest pain at 6.45 am on day of admission.
Died a few hours after admission.
ECG interpretation; No ECG taken
Post-mortem f indings : Septum and adjacent posterior wall
infarcted.
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Case 27
Age ; 70 years ’
Previous history; Three years previously had a myocardial
infarction.
History; Five episodes of dizziness in past week^ but did not 
lose consciousness. Complained of breathlessness 
on mild exertion.
ECG interpretation; Day 1- - left bundle branch block which dates
from infarction three years previously 
Day 2 - atrial fibrillation.
■ Fig. 2/2.28.
Case 28
Age ; 40 years
Previous history; Myocardial infarction two months previously, 
History : Tachycardia and left pectoral pain.
ECG interpretation; Supraventricular tachycardia and left
bundle branch block.
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Pigs. 2.2.29 - 2.2.33
Changes in serum enzyme activities in patients with cardiac
disease other than myocardial infarction and who were
.
treated by DC countershock.
0 Activity of creatine phosphokinase^ (CPK)^ in serum
Ak Activity of lactate dehydrogenase, (LDH), in serum
Denotes time of DC countershock.
Time zero on each figure represents 00.01 hours on day of DC 
countershock.
Note; Previous history refers to cardiac disease.
Fig. 2.2.29
Case 29
Sex: ■ Male
Age : 29 years
Previous history: Replacement of mitral valve three years
previously. •
History; Complained of weakness, breathlessness and 
palpitations.
ECG - interpretation; Atrial tachycardia.
Sex; Female
Fig. 2.2.30. 
Case 30
58 years
Previous history: Three years previously in congestive heart
failure and had atrial flutter.
History : Breathlessness and palpitation for last few weeks.
ECG 'interpretation: Left ventricular failure due to atrial
flutter.'
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Case 31
Sex; Female
Age ; 47 years
Previous history; Mitral stenosis and incompetence for three years 
History ; Complained of palpitation and breathlessness.
ECG interpretation; Atrial tachycardia
• Fig* 2 0.2 „ 32. 
Case 32
Sex ; Female 
Age: ■66 years
Previous history; None
ECG
Complained of frequent episodes of palpitations
interprétation: Supraventricular'tachycardia.
' .Fig*- 2 * 2 *'33
Case '33
Sex: Male
Age : 24 years
Previous history : Mitral and aortic valve disease for some years.
History: Mitral and aortic valve replacement six weeks previously. 
ECG interpretation : Atrial fibrillation,.'
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■ Figs'*- 2 /2/34 - 2 * 2 * 49.
These show semilogarithmic plots of the SCPK activities 
of some cases. The half-life of CPK in serum was 
calculated, in each of these cases and these are shown 
in Table 2.2.50.
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Table 2.2.50
Case
1 
2 
3 
■ 4
5
6
7
8 
10 
11 
12 
13
17
18
19
20
Half-lives of CPK 
in serum (hours) 
33 
18 
12 
18 
9
21 .
48
25
24
33
18
22
30
12
30
20
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2.3. Discussion
2.3.1. Patients with Suspected Myocardial Infarction
• All of the twenty-eight patients in this group were 
suspected on clinical grounds to have suffered a myocardial 
infarction. Synopses of the case histories are.given in 
■Section 2.2;
Twenty five of these patients, (cases 1 - 21, 23 - 26), 
showed increased activity in serum of either CPK and/or LDH 
and to that extent the enzyme assays bear out the correctness 
of the diagnoses. In almost every case it was possible to 
identify in the history given to the attending physician ' 
.(section 2.2.) a point at which the patient experienced 
chest pain of quite unprecedented severity, and this was 
taken as marJing the occurrence of the infarction.
2.3.1.1.Patients with Increased Serum Activities of CPK and LDH
  .....  - .'— ■■'■nr— — " "      ""    ■ "
In twelve of the 'patients (cases 1 - 3 ,  5 - 13) a- fairly 
complete pattern showing the rise and fall of the activities 
in serum of both of these enzymes was obtained. In almost 
all of these an increase in SCPK was unequivocally demonstrable 
within ten hours of the supposed infarct. The rise in SLDH was 
in most cases, somewhat less dramatic and was demonstrative 
within twenty hours of infarction,‘ ■ The SCPK activity usually 
reached a maximum within thirty hours and then declined rapidl^g
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The peak of SLDH activity was usually reached not much 
later, and its decline was slower, than that of SCPK. These 
results are similar to those of S^xensen (1963); Hess et al., 
lin (1964) ; Duma and .Siegel (1965) ; Smith (1967) , for CPK and
White (1956); Wacker et al., (1956);MacDonald, et al., (1957),
for LDH.
2.3,1.2.■ Mathematical Analysis of Serum Enzyme' Activities
It would be very helpful if it were possible, where 
reasonably complete data are available, to analyse mathematical 
; the rise and fall in serum enzyme activities. It is not diffic
to devise a simple mathematical model for release of the 
enzyme from the damaged muscle.into the blood-stream and for 
its subsequent disappearance and, on this basis, to calculate
. how the serum enzyme activities will vary with time.
Unfortunately.this possibility is more attractive in theory 
than in practice.
To take the simplest possible model one might assume 
that an infarction makes available to the circulation a finite 
quantity of enzyme x which will be released exponentially with 
a rate constant and that when it reaches the blood it will 
be removed by a second process, which we can assume will also 
be exponential, with a rate constant . We know that after
65
infarction there is a time delay, which we will denote by
t, before the release of enzyme from the damaged muscle begins
A model of this type will give a relationship between the
.serum enzyme level and time of the form shown in Fig. 2.3.1.
which is very roughly in agreement with the results obtained
in practice. In theory, given the shape of the curve found
experimentally, it should be possible to calculate the values
■ of the unknowns x, V^, V2 and t. Unfortunately, however, the
shape of the experimental curve, was defined by no more than,
on average, six to eight actual measurements, the number
.being limited by the fact that there was an obvious limit to
the extent to which an acutely ill patient could be subjected
to withdrawal of blood. This limited number of points was
quite insufficient to establish the shape of the curve in such
•an unambiguous manner as to permit calculation of x," 1 2
and t.
.3.1.3. Half-lives of SCPK
It would seem, from the results of experiments on animals 
by other workers (Dunn, Martins and Reissmann, 1958; Wroblewski 
and LaDue, 1955), that the removal of enzyme from the 
circulation is anl exponential process, and some of the data
6 6
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If an enzyme is released from infarcted muscle into the serum 
an exponential process of rate constant V. and is removed from the 
serum by a second exponential process of rate constant it: can 
be shown that the amount of enzyme, present e in the. serum at a ' 
given time a is given by the equation:
e = X (e - e -^2^)
where x is the total amount of enzyme made available by the 
infarction. The curve above shows the sort of result which' would 
be obtained if there is a delay (t) between the infarction and 
the start of the release of enzyme.
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obtained for SCPK activities were.accordingly replotted on 
a semilogarithmic grid (Figs. 2.2.34 - 2.2.49). The curves 
obtained tend to confirm that the fall in SCPK activity 
.after myocardial infarction is indeed exponential and allow 
one to calculate the half-life of CPK in serum for at least 
some patients^ Table 2.2.50.
It is of interest^ that, according to the calculations 
of Buecher, Schmidt and Schmidt, the half-lives of enzymes 
in the serum after myocardial infarction are much longer than 
those obtained from animal experiments (Hess, 1963).
2.3.1•4.. Patients' with Increased Serum Activities of either CPK or LDH
In a second group of patients only one of the two enzymes
showed increased activity in serum.
In cases 14, 16 and 17 SLDH was elevated, and it is to be
. noted that, in all three of these patients the increases began
on the third day. The possible explanations of this are;
1, Due to a lapse in time between onset of chest pain and
admission to hospital, the peak of SCPK activity was missei
2. The increased SLDH activity was not due to LDH of
myocardial origin.
In cases 14 and 16 both patients complained of severe chest pa;
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two and three days, respectively> previous to admission, and 
therefore, on the basis of this and the ECG evidence the first 
of these explanations is the more likely. In case 17 however
I#
. the situation was much more complex and we shall discuss
>• this patient in more detail later.
In cases 15 and 21 only the SCPK showed a slight increase 
in activity, and it may be that both of these patients 
suffered very slight myocardial infarctions which were not 
sufficient to produce a perceptible change in SLDH.
2.3.1.5. Incomplete Enzyme Curves . .
In cases 18 - 20 only the descending portions of the enzy 
curves were evident. In cases 19 and 20 this was probably 
due to the fact that the times 6f onset of infarction in these 
patients, according to the clinical histories, were more than
twelve hours before the first blood samples were taken off.
[2.3.1.6. Cases in which ECG.Evidence was not Indicative of Myocardial
Infarction
In most of the cases studied the clinical history, ECG 
■ evidence and serum enzyme results were in accordance with a 
diagnosis of myocardial infarction. However in a number of ca 
this was not so, and these fell into two categories which were
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1. Those patients in whom the ECG evidence was not 
indicative of myocardial infarction.
2. Those patients in whom the ECG evidence and serum enzyn 
results were not indicative of myocardial infarction. 
Cases 4, 12 and 17 fall into the first of these two cate 
gories, and we shall discuss these in detail.
In case 4 the patient suffered what was believed to be 
an infarction at about 4.00' am on the morning of admission 
and about twelve hours later developed ventricular fibrillat 
subsequently arrested and was then DC countershocked and 
successfully resuscitated. The ECG evidence in this patient 
was typical of antero-lateral myocardial ischaemia. The ser 
enzyme results showed very high SCPK and SLDH activities. 
Since elevated activities of SCPK are found only in diseases 
myocardial and skeletal muscle, acute brain damage, and 
hypothyroidism (Graig and Ross 1963) this enzyme is therefor 
the most specific of those at -present assayed for indicating 
myocardial ‘ necrosis (S^ zSrensen 1963; Hess et .al. , 1964; 
Coodley, 1966). Although only the descending limb of the, 
SCPK curve was evident in this particular case, the high 
values observed would seem, to indicate myocardial damage.
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The SLDH -activity was also extremely high, but,, since this 
enzyme is distributed over a large number of tissues, it 
shows increased serum activities in a considerable number of 
pathological states (Hill and Levi, 1954; Hsieh and Blumenthal 
1956). On the basis of the elevated serum enzyme activities, 
particularly that of CPK, the diagnosis favoured in this 
case was one of myocardial infarction.
In case 12 the ECG pattern was one of myocardial
ischaemia and this patient had had an infarction about eleven
•*
years previously. The patient complained of severe prolonged 
cardiab pain on both the second and third days and was also 
then in left ventricular failure (LVF). However this 
patient had definite increased activity of SCPK on the 
first and second days which eventually returned to normal on 
the fourth day. The SLDH activity reached a peak and 
started to descend within the first two days, but on the third 
day had risen again, and then slowly returned to normal over
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a subsequent period of three days. The possible explanations 
of this serum enzyme pattern are:
1. This patient suffered two infarctions, one on the evening 
before admission and one on the second day.
■2. This patient sustained an initial infarction and further to 
this developed congestive heart failure, (CHF), with 
accompanying hepatic congestion.
The two peaks of SLDH activity tend to support the first of 
'these explanations. However the sebond increase in SLDH 
activity may be due to hepatic congestion, as a result of 
CHF, Only one peak of SCPK activity was observed and this 
returned to normal relatively slowly. This, and the fact 
that this enzyme is not present" to any significant degree in 
hepatic tissue (Hughes, 1962; Sorensen, 1963), would support 
the second diagnosis
In case 17 the ECG evidence was also typical of 
myocardial ischaemia and this patient had a myocardial 
infarction about one year previously. The enzyme pattern
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in this■case■showed a small brief increase in SCPK with a 
long continuous elevation of SLDH, This patient improved . 
clinically for two days post admission then, on the fourth 
day, he developed atrial and ventricular fibrillation, 
subsequently arrested and was then DC countershocked, twice, 
the second time-being successful. The continued elevation c 
SLDH and not of SCPK in addition to the clinical evidence 
suggested a possible diagnosis of an initial myocardial 
infarction followed by the complication of CHF.
2.3.1.7, Negative Results
Cases 22, 27 and 28 gave negative serum enzyme results. 
In case 22 the ECG tracing was difficult to interpret and nc 
definite conclusions could be drawn from it. In cases 2 7 an 
28 the ECG showed left bundle branch block, (LBBB). Accord! 
to MacDonald et al., (1957), and Coodley (1970b), this syndr
masks ECG evidence of myocardial infarction, therefore in 
these cases the serum enzyme results would appear to be a me 
valuable diagnostic aid. It seems unlikely therefore that 
either of these patients had a myocardial infarction.
2.3.1.8. Estimation of Extent of Infarction
It has been suggested that the level- of activity.of 
SGOT is a valuable index of myocardial necrosis (Agress 
et al,, 1955; Nydick, Wroblewski and LaDue, 1955). We
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therefore studied the peak activities of SCPK and SLDH 
which we found in our patients in order to ascertain 
whether either of these was of use in estimating the extent 
of the infarction.
The SCPK activities varied greatly, in cases 1 - 6 ,  
they were extremely high compared to cases 7 - 13.' If we 
take the’ height of SCPK to be an index of the degree of 
severity of the lesion, then in cases 1 - 6  the damage to 
the myocardium was great. More than 50% (cases 1 - 3, 7 - 10 
the cases for which we had increased serum activities of both 
enzymes (cases 1 - 3, 5 - 13) had SCPK activities which were 
much greater than the corresponding SLDH activities. Coodley 
(1966) observed that the magnitude of elevation of SCPK was 
much greater than that of SLDH and he suggested that the heig] 
of the SCPK peak may be proportional to the extent of 
myocardial necrosis. Therefore it would appear that SCPK 
activity is a sensitive index of the degree of myocardial 
necrosis and this is also the view of Hess et al., (1964).
Our results would tend to agree with this.
We did not find any evidence to suggest that the level 
of activity of SLDH was an index of myocardial damage.
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2,3.1.9. Value o'f Serial Estimations of SCPK and SLDH in Prognosis 
In cases 1 " 4 the activities of both enzymes were 
tending to return to normal within two to four days of onset 
of infarction, however in cases 5 and 6 this was not so.
In case -5 the SCPK activity took four days, to return to 
normal then started to rise again and the SLDH followed 
a similar course, and this patient developed a pulmonary 
infarction on the fifth day. In case 6 the SCPK returned to 
normal within four days and the SLDH remained elevated and 
this patient died on the sixth day. In case 10 the explanat; 
of the secondary rise in SLDH was difficult since there was 
no evidence either in the clinical history or ECG to explain 
it, and this patient appeared to have an uneventful recovery 
In the other two cases, 12 and^17, the secondary and 
continued elevation of SLDH activity, respectively, was 
probably due to hepatic congestion as a result of CHF as 
previously discussed (section 2«3.1.6,), Therefore, with 
the exception of case 10, we may state that a continued 
elevation of SCPK activity and a secondary or continued 
elevation ofSLDH activity was indicative of a poor prognosis 
These results therefore agree with those of Sjz^ rensen 
(196 3), who found a mortality of 40% in patients with increa;
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SCPK ori the third day and hence concluded that if the SCPK 
was elevated for more than two days the prognosis was poor. 
The work of MacDonald et al., (1957), also agreed with our
findings on LDH since they found that a delay in return to 
normal or a secondary rise In SLDH activity implied a poor 
prognosis.
10. Deaths
Of the twenty-eight patients suspected to have had a 
myocardial infarction five died (case 6, 23 - 26). Case 6 
has been discussed in section 2.3.1,9. The cause of death 
in case 2 3 was probably a second infarction which gave rise 
to the rapid increase of SLDH activity observed. Those 
patients, cases 24 and 25, who died within twenty four hours 
of admission showed extremely high activities of SCPK and' 
SLDH, Case 26 also died very shortly after admission and 
therefore only one sample was obtained.
In these cases there was the possibility that the 
increased serum enzyme activities observed may have been 
reflective of the general critical condition of the 
patient- and not of damage to one particular organ.
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2.3.1.11. Effects of DC Countershock on SCPK and SLDH Activities
Three patients (cases 1, 4 and 17), were treated 
with DC countershock. After this treatment SCPK and 
SLDH activities rose in case 1, but in case 4 only 
SLDH■activity increased, and in case 17 neither enzyme 
was increased.
We therefore investigated the effects of DC 
countershock on these two enzymes in a small group of 
patients with cardiac disease other than myocardial 
infarction (cases 29 - 33). We found that in no case 
did shock treatment result in increased serum activities 
of either enzyme. Therefore, it appeared unlikely that 
the elevated SCPK and/or SLDH activities observed in 
cases 1 and 4 were caused by countershocking. However, 
it must be remembered that there was the possibility 
that the increased SCPK activity observed in case 1 
may have been due to brain ^ damage as a result of 
cardiac arrest (Fig. 2.1.2.).
c h a p t e r 3 - EFFECTS' OF OXYGEN THERAPY IN MYOCARDIAL
■INFARCTION '
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CHAPTER 3 - THE EFFECTS OF OXYGEN THERAPY IN MYOCARDIAL
INFARCTION
3.1., Introduction
3.1.1. Haemodynamic' Changes after Myocardial Infarction
It would seem reasonable to assume that any myocardial 
•« infarction, unless it was very,small, would impair the 
mechanical function of the heart and hence reduce cardiac 
output. The extent of the impairment would presumably be 
roughly proportional to the size of the infarction.
The haemodynamic changes:'in patients with acute 
myocardial infarction have been investigated by a number- 
of authors (Pritchard and Hellerstein, 1950; Gilbert, Goldber 
and Griffin, 1954; Lee, 1957; Broch, Humerfelt, Haarstad 
and Myhre, 1959 ; Murphy, Glick, "Schreiner and Yu, 1963). In 
general the results obtained by these workers show that in 
* most of the seriously■ill patients investigated there was
a fall in cardiac output accompanied by peripheral
mt-
vasoconstriction, whereas many of the moderately ill patients 
had low cardiac outputs but normal .peripheral resistance. 
Malmcrona and Varnauskas (1964), reported that patients who 
had a myocardial infarction and a high temperature had 
higher cardiac outputs than, similar patients with lower 
temperatures and attributed this to a fall in peripheral
78
resistance caused by the elevated temperature. Thomas, 
Malmcrona and Shillingford (1965a), found a wide variation 
in the haemodynamics of patients after myocardial infarction, 
some having high cardiac outputs and low peripheral 
resistance and vice versa.
3.1.2‘.’ Biochemical Changes after Myocardial Infarction
If the output of the heart is diminished and the 
circulation depressed after myocardial infarction it might be 
anticipated that metabolic changes would ensue. The cyanosis 
sometimes observed in patients with myocardial infarction 
might be an example of such metabolic upset.
One of the important findings made by previous investiga 
(MacKenzie et al., 1964; McNicol-et al., 1965; Valentine 
et al., 1966), who used small groups of patients, has been a 
reduction in the arterial blood oxygen tension. In addition 
they observed that when a myocardial infarction was associate 
with LVF and cardiogenic shock, the criteria for the latter 
being a low blood pressure, sweating and cyanosis, the 
hypoxaemia was even more marked, in the presence of considéra 
metabolic acidosis and lacticacidaemia. Increased levels of 
lactate in the circulation are generally accepted as evidence 
of anaerobic metabolism (Best and Taylor, 1961).
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3.1.3.,
The-practice of administering oxygen to patients with
myocardial infarction has long been established. One of
the first reports on the effects of oxygen therapy in these
patients was made by Barach who, in 19 31, had observed
that the pain associated with this condition could be
alleviated by inhalation of an oxygen enriched atmosphere.
However^subsequent to this Boland (1940), stated that only
high concentrations of oxygen were effective in relieving
the pain of these patients. It has been suggested that
oxygen therapy may also increase the tissue-oxygen tension
« # *
at the margin of the area of infarction (Sayen, 1951).
Thus, administration of oxygen has been recommended in 
the management of patients with, myocardial infarction (Dunlo; 
and Alstead, 1966; Friedberg, 1966). However the general 
effects of oxygen therapy were not studied at all until 
recently and then only in a limited number of cases 
(MacKenzie et al., 1964; Thomas, Malmcrona and Shillingford, 
1965 b; Cameron, Hutton, Kenmure and Murdoch, 1966).
The present investigation was undertaken in order to ■ 
establish, in a large series of patients, what haemodynamic 
and biochemical changes followed myocardial infarction and t
what extent these were modified or reversed by administratio 
of high concentrations of oxygen.
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3,2. Results
Fifty men with acute myocardial infarction were 
studied. Their ages ranged from 34 to 77, with a mean of 
57.6 years. The diagnosis was based on a history of 
cardiac pain lasting more than 30 minutes, of acute left 
. ventricular failure, or of unconsciousness, and was 
confirmed by ECGs which showed pathological Q waves and 
sequential ST-T wave changes. In all cases investigations 
were carried out within 24 hours of infarction.
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Table 3,2.1.
Haemodynamic Findings in 50 Patients with Myocardial T'n'farction, 
Breathing Air 
Case Heart
No.
Arterial Mean Arterial Cardiac
Rate B P
(per min. )
■ B.. P 
(mm Hg)
.Output 
(T/min)
Systemic
Vascular
Resistance
nes sec
cm )
(ml)
.1 125 1.35/90 . 105 4,83 1,739 39
2 68 127/65 86 8.70 791 128
3 58 105/45 68 2.00 2,720 35
4 54 124/60 80 5.76 1,111 107
, 5 72 80/52 61 3.50 1,394 49
6 Û68 112/90 97 6.24 1,243 92
7 56 75/40 52 . 3.70 1,124 . 66
8 100 137/65 85 . 7.01 970 70
9 66 150/90 110 • 6.21 •1,417 94
10 72 157/98 115 " 7.50 1,227 104'
11 80 ; 140/92 100 * 6.15 1,301 77
my
12 6 6 137/83 ‘ 94 3.80 1,980 58
f 13 124 152/85 95 4.45 1,708 36
' 14 100 75/47 57 5.20 877 52
15 70 114/55 80 4.44 1,441 63
16 ■ 120 125/75 80 7,83 817 65
17 120 112/55 70 9.55 586 80
# 18 80 65/30 50 4.93 811 62
19 84 117/70 87 5.68 1,225 68
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Table 3.2.1. (Continued)
Case
No.
Heart 
Rate 
(per min)
Arterial 
B P 
(ntaiHg)
Mean Arterial 
B P 
(inmHg)
Cardiac
Output
(1/min)
Systemic 
vascular 
.Resistance 
(dynes sec
20 72 110/45 62 7.19 690
¥21 60 102/55 70 5.59 1,002
22 68 87/45 60 3.84 1,250
23 64 140/82 102 3.66 2,229
24 ■‘-74 87/57 67 4.28 1,252
25 64 180/80 115 5.58 1,649
26 100 130/100 110 6.11 1,440
 ^27 57 100/52 68 3.47 1,568
28 56 108/74 88 4.53 1,554
29 83 96/58 68 4.41 . 1,234
30 8.3. 152/74 100 5.40 1,481
31 61 136/54 78 3.41 1,830
32 75 .240/137 180
>
3.61 3,989
33
m
83 . 100/64 80 5.80 1,104
34 115 106/74 88 2.82 2,496
t 35 102 60/40 44 1.32 2,667
36 107 150/96 114 5.17 1,764
37 82 118/84 96 3.46 2,220
38 88 160/104 116 6.16 1,506
39 96 125/53 68 4.66 1,167
¥ 40 48 116/56 77 3.30 1,867
41 90 100/48 62 5.79 857
"5
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m
Case 
No.
Heart ■ 
Rate 
(per min)
Table 3,2,1 » . (Continued)
Arterial Mean Arterial Cardiac
B. P
(mmHg)
B P 
(mmHg)
Output
(1/min)
vascular
Resistance
"5(dynes sec cm )
42 71 136/68 90 ■ 5.60 1,286 79
43 98 142/76 88 5.71 1,233 58
.44 81 116/70 81 5.08 1,276 63
M 5 81 140/91 110 5.63 1,563 69
46 .73 94/56 . 70 4.58 1,223 6 3
47 100 138/44 66 7.53 701 75
48 83 90/56 . 66 6.11 864 74
49
m
94 90/60 70 5.86 956 62
50 71 100/64 76 • 7.43 818 105
^Mean
Values 81 120/68 84 ■ 5.21' 1,424 66
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Table 3.2,2
Arterial Blood Oxygen and Carbon Dioxide Tensions, pH^ and Lactate 
and Pyruvate Concentrations in 50 Patients with Myocardial Infarctio] 
Breathing Air.
Case . PaCO^ £H Lactate
No. (mmHg) (mH) (aülii
1 6 9 37 7.42 — —
2 85 36 ' 7.45 — -
3 : 86 39 7.46 - -
4 98 17 7.58 2.55 —
5 97 38 7.33 — -
6 97 — — - -
7 88 40 7.30 — -
8 53 38 7.43 — —
9 90 44 7.40 - —
10 ■ 67 39 7.46 -
11 50 34 7.44 ' 1.36 —
12 100 ; 39 7.40 — -
13 43 29 7.47 1.66 0.05
14 24 37 7.25 5.70 0.17
15 61 37 ' 7.45 . 1.97 0.05
16 63 41 7.45 2.5 3 0.04
17 84 32 7.44 3.36 0.03
18 70 37 7.40 2.02 0.04
19 59 35 7.52 0.91 0.08
20 61 34 7.48 .
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Table 3.2.2. (Continued)
Case Pa02 PaCO,, ES Lactate ■ Pyruvate
No. (mmHg) (mn^) XmüL ■ ImMV.
21 ■ 52 34 7.50 2.50 0.05
22 60 37 7.50 0.87 0.05
2 3 81 31 7.53 2.58 0.06
24 82 33 7.46 1.32 0.04
25 54 39 . , 7.45 1.28 0.04
26 51 44 " 7.40 1.63 0.04
27 65 4 6 7.47 l.#3 0.03
28 70 42 7.44 1.51 0.02
29 51 37 7.38 1.22 0.06
30 56 45 - 4.72 0.02
31 6 8 - 1.26 0.01
32 58 “ 4.49 0.01
33 56 37 7.45 2.74
>
0.02
34 73 35 7.32 6.65 0.03
35 54 .32 7.35 7.06 “
36 73 36 7.45 — -
3^ 59 39 7.48 1.48 0.06
38 61 41 7.43 1.15 0.04
39 34 40 7.39 ■' 2.81 0.09
40 59 47 7.41 0.50 0.02
41 79 41 7.42 1.31 0.03
42 73 34 7.43 ■ —
86
Table 3.2.2, (Continued)
Case
No
43 .
44
45
46 
47: '
48
49
50
Mean
2 ^ 2
(mmHg)
63
51
72 
56
73 
51 
28 
62
PaCO^
(mmHg)
35
35
39
40 
39 
32 
35 
35
ES
7,42 
7.55 
7.48 
7.45 
7.37 
. 7.50 
7.44 
7.51
Lactate
(mM)
2.48
2.01
4.06
0.73
3.13
3.37
3.78
2.60
Pyruvate 
, (mM) 
0.04 
0.02 
0.02 
0,04 
0.02 ' 
0.08
Values 65 37 7.44 2.52 0.04
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T ab l e' 3.2.3,
Haemodynamic Findings in 50 Patients with Myocardial Infarction,
Breathing approx* 100% Oxygen
Case Heart Arterial Mean Arterial Cardiac
No. ■Rate B. P B P Output Vascular
(per min) (mmHg) I. (1/min) Resistance 
(dynes sec
1 117 137/92 107 4.56 1,877
2 ■ 66 136/70 92 6.51 1,.131
3 55 125/60 82 1.73 3,791
4 58 154/64 98 . 4.66 1,682 .
5 71 77/55 62 3.48 1,425
6 70 120/77 90 4.97 1,448
7 58 .77/40 60 3.85 1,247
8 96 155/80 107 ' 5.14 1,665
9 . 66 158/120 133 ■ 5.45 1,953
10 76 180/112 142 ■ 5.70 1,993
11 76 140/82 100 5.96 1,343
12 70 138/90 105 3.62 2,320
13 112 150/90 ■ 100 4.16 1,923
14 108 107/65 77 4.66 1,322
15 68 145/70 88 4.14 1,700
16 . 100 110/67 82 6.66 985
17 110 117/60 77 7.78 792
18 6 4 87/42 54 3.44 1,256
19 84 125/70 90 4.92 1,463
20 74 120/60 75 6.65" 902
S
V
(
-5
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Case Heart
Table 3,2,3 „ (Continued) 
Arterial Mean Arterial Cardiac
No. Rate BP, B P Output Vascular Voli
) CmmHg) (mmHg) (1/min) Resistance 
(dynes sec cm ^)
(nl
21 56 102/52 70 ■5.42 1,033 9"
¥ 22 58 97/55 70 4,15 1,349 7;
23 66 •125/75 95 3.56 2,135 5-
^ 24 82 113/75 , 88 4.40 1,600 5'
25 •’ 76 ^ 180/90 125 5.88 1,701 7
26 100 140/110 124 4.53 2,190 4,
27 55 132/66 88 3.77 1,867 6
« 28 54 122/72 . 94 4.10 1,834 7
29 83 94/60 72 3.41 1,689 4
m
30 83 152/68 96 . 5.16 1,488 6:
31 42 76/28 44 ,2.03 1,734 4
32 65 ■ 230/125 160 5,39 2,375 8
33 85 132/72 90 '■ 5.01 1,437 '5
34 ‘116 ; 102/66 80 ' 3.11 2,058 2
35 114 52/40 40 2.56 1,250 2
^ 36 125 154/100 . 118 4.96 1,903 4'
37 70 134/74 94 3.67 2,049 5
38 88 162/112 126 5.57 1,810 6
39 105 14.6/71 97 3.79 2,047 3
^ 40 51 116/58 82 3.63 1,807 7
41 99 102/50 72 5,25 1,097 5
42 74 132/64 88 5.86 ; 1,201 ■ 7
89 .
Table 3.2.3, (Continued)
Case Heart Arterial Mean Arterial Cardiac Systemic
H£* Rate B P B P Output •Vascular
(per min) (mmHg) (mmHg) (^min)
iri «■ ■ 1 mil
Resistance 
(dynes sec
43 89 144/74 100 4.73 1,691
44 ' 96 126/70 96 .4.64 1,655
45 92 145/95 110 '5.72 1,538
46 73 106/62 ■ ‘ 72 4.28 1,346
47 99 150/70 100 6.41 1,248
48 93 112/62 78 5.63 1,108
49 108 92/64 73 6.27 931
J» 50 69 , 136/70. 92 6.41 1,148
m
Mean
Values 81 127/72 91 ' 4.75 1,610
” 5
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Table 3.2.4.
Arterial Blood Oxygen andCarbon Dioxide Tension, pH and Lactate and
%
Breathing approx. 100%
Case PaO^ PaCO^ pH Lactate P
No. (mmHg) (mmHg) '(mM) ■ (mM)
1 575 26 7.55 — —
2 430 . 34 7.47 - -
3 . - 491 36 7.41 -
4 486 30 7.58 1.54 "
5 295 32 7.42 — —
6 538 — — — ""
7 522 44 7.30 - - —
8 261 42 7.40 —
9 435 40 . 7.53 ""
10 281 39 7.37 -
11 260 35 7.44 '1.06 -
12 342: 39 7.38 — -
13 390 34 7.47 1.97 0.04
14 141 36 7.37 4.54 0.16
15 367 33 7.44 1.66 0.08
16 470 38 7.46 1.18 0.04
17 423 41 7.47 2.58 0.03
18 ,406 38 7.44 2.07 0.03
19 406 39 7.51 1.33 0.04
20 496 36 7.45
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Table 3.2.4* (Continued)
Case PaCO^ pH Lactate Pyruvate
No. (mmHg) (mmHg) • (mM) (mM)
21 481 31 7.55 1.56 0.04
22 565 37 7.49 1.18 0.05
23 542 31 7.49 1.95 0,06
24 603 36 7.45 1,33 0.03
25 366 ■ 42 7,. 4 3 1.33 0.05
26 ■ ’ 486 41 7.38 1.35 0.04
27 625 46 7.48 0.68 0.02
28 610 50 7.47 0.77 0.02
29 459 39 7.44 0.99 0.05
30 496 48 ^ 7.32 3.40 0.03
31 378 — * — , 1.23 0.02 ,
32 475 — - 3.36 0.01
33 423 43 7.42 - 1.43 0.03
34 649 34 7.33 \ 2.33 0.04
35 181 ; 35 7.32 ' 6.43 —
36 452 37 . 7.45 • - —
37 440 44 7.42 1.07 0.02
38 474 50 7.37 0.63 0.02
39 237 45 7.35 2.13 0.05
40 542 39 • 7.50 0.49 0.04
41 571 4 3 7.43 1.46 0.04
42 311 30 . 7.48
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Table 3.2^4, (Continued)
Case
44
45
46
47
48
49
50
Mean
PaO.
No. (itunHg) 
43 396
510
555
435
237
441
395
305
PaCO^
' (mmHg) 
38
36 
27
41
42
37
36
37
pH
7.44 
7.57 
7.52
7.45 
7.38 
7.43 
7.44. 
7.48
Lactate
(mM)
1.20
1.04
0.96
0.55
2.29
2.46
3.38
3.33
Pyruvate
(xnM)
0.02 
0.02 
0.01
0.03
0.03
0,06
Values 433 38 7.44 1.82 0.04
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3.» 3 / Discussion
3.3,1. gaemodynamlc Findings' while 'Breathing Air
The haemodynamic findings before oxygen are shown in 
Table 3.2,1, Even on casual inspection it is apparent 
that there were wide variations between individuals in 
all the parameters measured. The heart rate varied from 
.V 48 to 125/minute, mean arterial pressure from 44 to 
180 mmHg, cardiac output from 1.32 to 9.50 1/minute, 
stroke volume from 13 ml to 12 8 ml and systemic
-5vascular resistance from 586 to 3,9 89 dynes sec cm 
There was no very obvious correlation between most of the 
parameters measured. There was however a direct relationship 
between cardiac output and.stroke volume (Fig, 3.2,5,) and 
an inverse relationship between cardiac output and systemic 
. vascular resistance (Fig, 3,2,6.') .
The average value for each of the haemodynamic measureme: 
was remarkably close to normal. One cannot say of course 
what the corresponding figures would have been for each 
■ individual patient immediately before infarction occurred, 
but it seems reasonable to conclude that infarction does 
not produce a consistent pattern of haemodynamic changes.
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3.3.2. Biochemical Findings while Breathinq Air
The corresponding biochemical findings are shown in 
Table 3,2’, 2, Again there was a striking variation between 
individuals, arterial blood oxygen tension (PaO^), varied 
from 2 8 to 100 mmHg, arterial blood carbon dioxide tension, 
(PaCO^), varied from 17 to 46 mmHg, pH from 7,25 to 7.58, 
arterial blood lactate from 0,50 to 7,05 mM and arterial 
blood pyruvate .from 0,01 to 0.17 mM, As in the’ haemodynamic 
findings there was little correlation between these quantities 
PaO^ and PaCO^ showed no relationship, but there was' a 
suggestion of one between pH and PaCO^, particularly if cases 
with high lactate values were excluded (Pig, 3,2.7.).
With two exceptions the average values obtained for 
these biochemical parameters were normal. The exceptions 
were PaO^ which gave an average value of 65 mmHg where 
one would normally expect a value of 100 mmHg, and arterial • 
blood lactate which had an average value of 2.52 mM instead 
of one in the normal range of 0,10.to 1.78 mM.
We could not find any correlation between the 
haemodynamic and biochemical results,
3.3.3. Haemodynamic Effects of Oxygen Therapy
The effects of administration of high concentrations of 
oxygen on the haemodynamic measurements are shown in 
Table 3.2.3. The effects on heart rate and blood pressure
98
were remarkably small. On the other hand however the 
average cardiac output and the stroke volume were significani 
diminished after oxygen and the systemic vascular resistance 
was increased (p<0.001 for all three of these parameters). 
Again it was notable that changes in individuals, though, 
consistent, were seldom dramatic.
3.3.4. Biochemical Effects of Oxygen Therapy
The corresponding biochemical changes are shown in Tabl<
3.2.4. Oxygen therapy does of course produce a tremendous 
,increase in PaO«. Although the oxygen was administered by 
an efficient method the values of PaO^ attained were variabl< 
and showed no obvious correlation with the PaO^ values in ai: 
The effect of oxygen on elevated blood lactates was, in all 
but o,ne case (no 18), to reduce, it. The average PaCO^, 
pH values arid blood pyruvate levels were not much altered 
by oxygen and where changes did occur in individuals they 
were generally not great and did not exhibit any intelligibl 
pattern.
3.3.5, Possib 1 e Explan''a't'io'n's-o'f; the's'e'; yj'ndi'ngs
The most striking feature of these results is the low 
arterial blood PaO^, arterial hypoxaemia, found in almost
9 9
all of the fifty patients investigated* The explanation 
of this is not however absolutely clear. It has been observi 
that pulmonary oedema is sometimes a complication of 
myocardial infarction (Malmcrona and Varnauskas, 196 4; 
McNicol et al*, ,1965) and is frequently associated with 
arterial hypoxaemia., both in man (Cosby, StOwell, Hartwi^g an' 
Mayo, 1957) and animals (Williams 1953; Fcrster 1957). Since 
arterial hypoxaemia is almost invariably found in myocardia- 
infarction it may be that a similar process to pulmonary 
oedema occurs, but to a lesser- degree which is not clinical! 
detectable, in these cases* Therefore it seems most likely 
' that this hypoxaemia is a consequence of impairment of 
respiratory function. This impairment could be either 
inadequate ventilation, veno-arterial shunting, ventilation/ 
blood flow inequality or incomplete diffusion of gas within 
the terminal airways, or a combination of these (West, 1966) 
Whatever may be the cause of arterial hypoxaemia after 
infarction the question is whether or not it is harmful to t 
patient and if so does oxygen therapy have a beneficial effe 
Although decreased blood-tissue oxygen tension gradient 
have been found in myocardial infarction and been attributed 
to disturbance of pulmonary function and diminished tissue
perfusion (Valentine et al., 1966) arterial hypoxaemia
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does not always imply tissue hypoxia. The rate at -which 
oxygen is made available to the tissues depends on the 
product of the cardiac output, haemoglobin concentration 
and arterial oxygen saturation. In the patients we studied 
the average PaO^ before oxygen was administered was 65 mmHg 
although this was only 2/3rds of the normal level it still 
corresponded to 90% saturation of the haemoglobin (Fig. -3.3 
In other words in spite of the substantial fall in PaO^ the 
oxygen content of the blood was nearly normal. In the norn 
subject it would be anticipated that the PaO^ of mixed venc 
blood would be approximately 40 mmHg and this would corresg 
to approximately 75% saturation with oxygen (Fig. 3.3.1).
If we assume the same quantity of oxygen is withdrawn from 
the .‘blood of a normal healthy person, the PaO^ in the venot 
blood of the patient would be around 32 mmHg. Therefore, i 
these patients, although the same quantity of oxygen is 
available to the tissues after infarction as before the 
oxygen would be liberated in the PaÛ2 range 32 to 65 mmHg 
instead of the normal range of 40 to 100 mmHg. This would 
not be a particularly drastic change since only a small 
proportion of the oxygen yielded up in normal circumstances 
is given off at high tensions. If however the PaO^ were as
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M
low as 28, mmHg corresponding to 60% saturation with 
oxygen (Pig. 3,3.1) the situation would be rather different. 
Assuming that the same quantity would be taken from the 
circulating blood, the returning venous blood would be only 
35%. saturated and oxygen would be made available to the 
tissues in the pressure range 18 to 28 mmHg. Therefore only 
in cases of severe arterial hypoxaemia would one expect 
to.find tissue hypoxia and the consequent acidosis and 
lacticacidaemia.
3.3.6. Cardiogenic Shock
In the present series of experiments there was a 
number of patients (nos 3,5,7,14,18,34 and 35) who, on the 
.grounds of either low cardiac output or blood pressure or 
both, could be considered to be in a state of cardiogenic 
shock. Cases nos 3,.5 and 7 had low cardiac outputs and 
PaO^s hear normal, cases nos 14 and 18 had normal cardiac 
outputs and reduced PaO^s, cases 34 and 35 had reduced 
cardiac outputs and PaO^s. These results could possibly 
be explained by veno-arterial shunting, since failure of the
I
hearts ability to pump is the primary factor in cardiogenic 
shock (MacKenzie’ et al. , 1964) .
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Three of these cases (nos 14,34 and 35) were acidotic an 
had high arterial blood lactates and two of these (nos 14 and 
35) died within the first forty-eight hours while oxygen was 
being given continuously.
In general the effects of oxygen therapy in these cases 
were slight. The PaO^s were appreciably increased in cases 
nos 3,7,18 and 34 but not in cases nos 5,14 and 35. The 
arterial blood lactate was considerably reduced after oxygen 
therapy in case no 34 but not in cases nos 14 and 35.
3.3.7. The Value of Oxygen' Therapy
As we have seen the effect -of oxygen on the haemodynamic; 
was to increase the systemic vascular resistance and 
presumably in consequence to diminish the stroke volume and 
cardiac output. These results are similar to these obtained 
■ after administration of high concentrations of oxygen to 
normal man at rest (Daly and Bondurant, 19 62? Eggers, Paley, 
Leonard and Warren, 1962).
Our results indicate that administration of high 
concentrations of oxygen greatly increased the PaO^ in patient 
who were moderately ill but in cardiogenic shock the PaO^s
Were appreciably increased in only some cases.
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Therefore we may conclude that oxygen therapy is 
beneficial in moderate cases of myocardial infarction to 
the extent that it tends to increase blood pressure, 
systemic vascular resistance and PaO^ and decrease 
elevated arterial blood lactates. However the value of 
oxygen in severe cases of myocardial infarction is doubtful
■ CHAPTER 4'" - CONCLÜSTONS
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CHAPTER 4 - CONCLü.SÎONS
4*1. Serum
On examination of this section of the work the first 
conclusion which was drawn was that estimations of SCPK and 
SLDH were valuable diagnostic aids in cases of suspected 
myocardial infarction. In addition we found that serial 
estimations of. these two enzymes, as opposed to one, provided 
much additional information about the course of the disease 
and the prognosis. CPK appeared to be a more sensitive index 
of myocardial damage than LDH and it may be that the level of 
SCPK activity was proportional to the extent of the infarctio: 
Elevated activities of SCPK on the third and fourth days seemi 
to indicate a poor prognosis. LDH although not so specific f« 
‘myocardial damage as CPK was particularly useful in those cas' 
where admission to hospital had been delayed, since it exhibi 
increased activity in serum later than CPK. In those cases 
where the ECG evidence was difficult to interpret, for example 
where previous infarctions had occurred or where there was LB: 
the assay of these two enzymes proved invaluable, and CPK was 
particularly valuable in this respect.
Since there, seemed to be a definite time relationship 
between the onset of the infarction process and the start of 
the elevation of SCPK and SLDH activities we attempted to 
analyse our results mathematically.' We concluded that
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estimations of serum enzymes at four to eight hourly 
intervals were insufficient and in order to do this it would 
be necessary to take numerous blood samples at intervals of 
k to 1 hour until the peaks of the enzyme activities were 
reached. We also found that the activity of CPK in serum 
appeared to follow an exponential course and were therefore 
able to calculate the half-life of this enzyme in some cases 
As a number of our patients with myocardial infarction 
were treated by DC countershock we therefore investigated th 
effects of this, on patients with cardiac disease other thar 
myocardial infarction, with respect to SCPK and SLDH. In nc 
case was the activity of either SCPK or SLDH increased by 
such treatment,
• Our results illustrated a number of practical points. 
Firstly they showed‘that when working with serum enzymes th« 
time factor was of primary importance. Therefore in order 
to get the maximum information in these cases it is essenti 
to obtain blood samples as soon as possible after onset of 
the infarction process and frequently thereafter. We also 
concluded that it was advantageous to assay for enzymes whi 
one would expect to have different time courses in serum 
e,g, CPK which showed an early, short-lived increase and -
•ft
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LDH which showed a somewhat later and longer-lived increase.
Finally, we concluded that in every case the serum 
enzyme results must, be interpreted in conjunction with both 
the ECG evidence and the clinical history.
4.2. The Effects of Oxygen Therapy in Myocardial Infarction
The first conclusion drawn from this section of the wor
was that in most of the patients investigated the haemodynair
and biochemical results, before oxygen therapy, were remarks
close to normal. The one general finding .-was that almost
all of these patients exhibited' some degree of arterial
hypoxaemia. Only in those patients who were severely ,ill di
we find any appreciable fall in cardiac output and/or blood
pressure, and arterial blood lactate levels much above norme 
. c
The effects of administration of high concentrations oj
oxygen were, in general, to raise the blood pressure, syster
vascular resistance and PaO^ and reduce the cardiac output,
stroke volume and arterial blood lactate. Since oxygen
therapy did not, to any great extent, alter the haemodynami<
and metabolic findings in severely ill patients we conclude'
that it was of little benefit in these cases.
APPENDIX ' -■ ■ MATERIAL'S' AND' METHODS
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MATERIALS AND METHODS 
■ Analyses were carried out in all cases with minimum delay 
after withdrawal of the blood specimen. When this was not 
possible serum was stored at 4^C, and plasma and deproteinised 
blood at -10*^ C. Serum enzymes were always estimated within 
24^hours, arterial blood lactate and pyruvate and concentration 
of dye in plasma within 48 hoursh Each analysis was repeated 
until consistent results were obtained.
1. Enzyme Assay Methods
a* Estimation of Creatine' Phosphokinase 
Principle
This enzyme was estimated in serum by the method described 
by Rosalki (1967), whereby the change in extinction at 34Qim 
(A e ^^q ) due to the conversion of the oxidised form of 
nicotinamide adenine dinucleotide phosphate (NADP ) to its 
reduced form (NAPDH) is measured. Adenosine triphosphate.'(ATP) 
formed by the action of the enzyme on adenosine diphosphate 
(ADP) and creatine phosphate (CP) is linked to the reduction
j.
of NADP with- glucose, hexokinase (ATP s D-hexose 6 - phospho­
transferase EC 2 .7 .I.I0) and glucose - 6 - phosphate 
dehydrogenase (D-giucose - 6 - phosphate : NADP oxidoreductase 
EC 1.1.1.49) (G - 6 - PDH). .
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CPK
1* ADP 4- CP ATP P creatine
hexokinase
2. ATP t glucose --- ------- glucose-6-phosphate ADP
G-6-PDH3. Glucose-6-phosphate 4- NADP ------  ^ 6-phosphogluconate
4- N A P D H  4-
The A E at 340nm provides a measure of CPK activity. 
Reagents :
The test capsules manufactured by Calbiochem were used*
These containeds
1* Substrates 0*001 M-ADP, O.OlM-CP, 0.02M-glucose, 0.03M-
magnesium chloride, hexo*kinase (0.6 U/ml) , G-6-PDH (0.3 U/ml) ,
4“0*008 M-NADP in concentrations chosen to provide optimal 
reaction conditions.
2o 0.OlM-adenosine monophosphate (AMP), •
3, 0.05M-cysteine hydrochloride*
The reagents were dissolved in 0.05 M - tris buffer and the 
final pH adjusted to 6.8 at 25^C and then freeze dried.
The capsule contents were reconstituted immediately prior to 
assaying by the addition of distilled water. This  ^ activated^ 
substrate was kept ice-cold and was not stored.
Method
Measurements were carried out on a Unicam SP 500 series 
2 spectrophotometer with an SP 505 programme controller and
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a thermostatically controlled cuvette carriage. The 
reaction took place in a 1 ml silica cuvette with a 1 cm 
light path.
1 ml of ’activated® substrate was pipetted into the,test 
cell and allowed to equilibrate to 30*^ C. 25 yu 1 of , serum
were blown into the test cell and gently mixed. After a 
pre-incubation period of 6 minutes the extinction at 340nm 
(E3 4 0) was recorded and this was repeated every minute for the 
next fifteen minutes. Measurements were made against a 
distilled water blank.
Units
. The unit of enzyme activity (U) was as recommended (1964) 
by the International Union of Biochemistry which was ’One 
unit of any enzyme is that amount which will catalyse the 
transformation of, 1 micromole yx. mole) of substrate per 
minute under standard conditions.
1 milli-Unit (mU) = 0.001 U.
C aleu1ation
'The Molar Extinction Coefficient (^ ) of NAPDH at 340nm
is 6.22 X 10^ 1 mol ^cm ^
Activity =' ^ .10.0.0.. .X V
6.22 X V
Ill
where V = total assay volume in ml, and v = sample 
volume in ml.
Activity = A E/minute x 6,4 30mU/ml
b. Estimation of Lactate Dehydrogenase
All LDH assays were performed on .unhaemolysed serum 
specimens.
The method used to estimate LDH in serum was an adaptation 
of that of Wroblewski and LaDue (1955), whereby the change 
in extinction at 340nm (A^E^^q ) due to the conversion of the 
reduced form of nicotinamide-adenine 'dinucleotide (NADH) to 
its oxidised form (NAD ) is measured. The.reductioncof 
pyruvate to lactate by NADH is catalysed by LDH*
Pyruvate t NADH t H~^  ^ .... Lactate 4- NAD*^
The A E  at 340nm provides a measure of the LDH activity. 
Reagents
The test combinations manufactured by the Boehringer 
Corporation (London) Ltd. were used.
Buffered substrates 0,05M-phosphate buffer, pH 7,5?
0 * 003M-pyruvate.
0.009M-NADH
Method
Measurements were carried out as for CPK using a 
3 ml silica cuvette of 1 cm light path.
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3 ml of reagent 1 were pipetted into the test cell and 
allowed to equilibrate to 25‘^C. 1 0 0yul of serum were then 
added and gently mixed* The extinction at 340nm was
recorded immediately_and thereafter every minute for the 
following ten minutes*
If the serum gave an greater than 0*20/minute -it
was diluted 1 in 10 with physiological saline * • -
■ E ^ i b s
As for CPK*
Calculation
• As for CPK since (;i,of NADH is 6*22 x 10^ 1 mol  ^cm 
Activity = A E/minute x 5,06 4mU/ml
For diluted samples the result was multiplied by 10*
2 o Lactate and Ev r u. va t e As say Methods 
D e pro te i n i z a t ion of Blood
Immediately after withdrawal, without stasis, blood 
samples were vigorously mixed with 3,5% (w/v) perchloric 
acid volume to volume, centrifuged at 1400 g for 20 minutes 
and the supernatant decanted and assayed* 
a * Es t ima t ion o f Arter i a1 Blood Lac t at e 
Principle
tLDH catalyses the oxidation of lactate by NAD
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Lactate t NAO"^ "  -----— Pyruvate t NADH t
 —
In order to obtain quantitative oxidation the 
reaction products were removed, protons by using an 
alkaline reaction medium and pyruvate by trapping with 
hydrazine*
Lactate t NAD^ t hydrazinepyruvate hydrazone
. + NADH + 3
-L
Since this is a stoichiometric reaction (1 mole NAD / 1 mole 
lactate) it is possible to calculate the lactate concentration 
by following it.
The test combinations manufactured by the Boehringer 
Corporation (London) Ltd* were used*
1* 0*5M-glycine buffer, pH 9*0? 0*4M-hydrazine 
2* LDH (2 mgms/ml)
3, 0.027M-NAD'’'
Method
Measurements were carried out oh a Hilger Watts 
spectrophotometer with a thermostatically controlled cuvette 
carriage* 3 ml silica cuvettes with a^ 1 cm light path were 
used*
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Tests 2 mU reagent 1, 0*10 ml supernatant, 0*03 ml reagent 2,
0*20 ml reagent 3*
Blanks 2 ml reagent 1, 0*10 ml 3*5% (w/v) perchloric acid,
0*03 ml reagent 2, 0*20 ml reagent 3*
After an incubation at 25^0 for 1 hour the E at 340nm of 
test and blank were used.
Oal eu1at i on
£ 240 NADH is 6 * 22 x 10^ 1 mol  ^cm ^
A E X  VConcentration of lactate in ■ cuvette - -rrrr'— ^ mM
6*22 X V
Concentration' of lactate in whole blood = x  F mM
6*22 X  V
Where V = total assay volume in ml _ v == sample volume in ml,
F.= dilution factor*
Concentration of lactate in whole blood = Ae x  7*5mM* 
b* Estimation of Arterial Blood
LDH catalyses the reduction of pyruvate with NADH
Pyruvate t NADH f H"^ -----  ^Lactate t NAD*^
Pyruvate is quantitatively converted to lactate* This 
is a stoichiometric reaction (1 mole NADH/1 mole pyruvate) 
therefore the pyruvate concentration is measured by following it
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Reagents
The test combinations of the Boehringer Corporation 
(London) Ltd» , were used»
IL 2o2M”dipotassium hydrogen phosphate (K^H PO^)
2» 0»012M“NADH 
3o LDH (0„75 mgm/ml)
Method
Measurements were made as for lactate»
1 ml of reagent 1 was added to 3 ml supernatantmixed^ and 
allowed to stand in an ice-bath for at least ten minutes »
The resultant supernatant was filtered off and the filtrate 
allowed to equilibrate to 25^C« 2 ml of filtrate was pipetted
into a cuvette'and 0»05 ml of reagent 2 added^ mixed and 
E340 read» 0«05 ml of reagent 3 was then added to the 
test cell^ mixed^ and -E^^Q was read after 5 minutes » 
Calculation
As for lactate except A E  must be corrected for dilution 
caused by addition of LDH
Concentration of pyruvate in whole blood = A E x O » 5mM»
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Estimation of Dye (Zone en t rat l'on i n P1 a sraa
Cardiac output was measured by a dye-dilution technique^ 
the procedure described by Taylor and Shillingford (1959); 
being followed» The calibration of the dye dilution curve 
requires the measurement of the concentration of dye^ in 
this case Coomassie Blue^ in plasma and to do this we used 
a modification of the method of Clausen and Lifson^ , (1956) » 
Method
To each plasma sample (one before and one after injection 
of dye)g and two standards (standard 1 - 2 0  mgms dye/1  ^
standard 2 - 1 0  mgms dye/1 )^  the following were added»,
2 ml saturated urea 
4 ml acetone
0»5 ml ZnSO.g 7H 0 (10% w/v)
0»5 ml NaOH (0.5M)
The tubes were shaken after each addition^ and after 
centrifugation at 700 g for 15 minutes the supernatant was 
pipetted off and their E at 575 nm read against an acetone 
blank» Measurements were made in a Unicam SP -600 
spectrophotometer using a 3 ml glass' cuvette with a 1 cm 
light path»
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C a l c u l a t i o n  E - E '
s bConcentration of dye in plasma =___ mgm/1
E
st
(E^ - E of  s a m p l e  p l a s m a ;  E^  ™ E of b l a n k  p l a s m a ;  E ^ ^  - 
E of s t a n d a r d ) » T h i s  w a s  m u l t i p l i e d  b y  the h a e m a t o c r i t  to 
g i v e  the c o n c e n t r a t i o n  of d y e  in w h o l e  b l o o d »
Estimation of Aterial Blood Gases and pH
Oxygen was administered by means of a close-fitting 
face-mask connected to a humidifier and low-resistance demand 
valve (McDowall ; Ledingham^, Jacobson and Norman y 1965) »
Blood gases and pH were measured using an Instrumentation 
Laboratory Inc. system (Model I.L.113)» The arterial oxygen 
tension (PaO^) was measured by a Clark electrode y carbon 
dioxide tension (PaCO^) by a Severinghaus electrode and pH - 
by a glass electrode. The system was calibrated using nitrogeny 
oxygen y carbon dioxide and nitrogen -mixtures of known 
composition and buffers of known pHy and tonometered blood.
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SUMMARY
This work consists of two main sections » In the first 
of these we investigated the value of serum enzyme assays in 
cases of suspected myocardial infarctiono The second part 
was concerned with the effects of oxygen therapy on patients 
^ who had had a myocardial infarction
Serial assays of serum creatine phosphokinase^ (SCPK)y 
and serum lactate dehydrogenase (SLDH) ; were carried out 
in a group of twenty-eight patientso From the results 
obtained we assessed the value of such estimations in 
confirming; or otherwise ; the' diagnosis ; in following the
course of the disease and in prognosis» We found that there
was a definite relationship between onset of the infarction 
process and the commencement of increased activities in 
serum of both of these enzymes» In general SCPK activity 
started to rise; reached a peak/ and returned to normal 
more rapidly than did SLDH » The assay of these two enzymes ; 
as opposed to one ; proved to be of. value in following the
course of the disease» _SCPK appeared to be a more sensitive
index of myocardial necrosis than SLDH and it seemed likely 
that the level of activity of this enzyme in serum may have 
been proportional to the extent.of myocardial damage»
Since a number of these patients were treated by 
direct current; (DC); countershock we investigated the effects 
of this in a small group of patients with cardiac disease other
than myocardial infarction» In no case did we find that this
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treatment gave rise to increased SCPK and/or SLDH activities»
■Haemodynamic and biochemical measurements were carried 
out ; before and after administration of high concentrations of 
oxygen ; on a group of fifty patients who had had a myocardial 
infarction within the previous twenty-four hours » The 
haemodynamic parameters measured were heart rate ; blood pressure 
cardiac output ; systemic vascular resistance and stroke volume. 
The biochemical measurements were arterial blood oxygen and 
'Carbon dioxide tension; pH; and lactate and pyruvate concentrati 
In general we found that the values of most of these parameters 
Were close to normal and only in the severely ill patients was 
there a fall in cardiac output and/or blood pressure ; and a rise 
in arterial blood lactate of any significance» The only consist 
finding was that almost all of these patients exhibited some 
degree of .arterial hypoxaemia» The effects of oxygen therapy 
were; in general; to raise the blood pressure; systemic vascular 
resistance and arterial blood oxygen tension ; and to lower the 
cardiac; output; stroke volume and'arterial blood lactate 
concentration» We found that oxygen appeared to have little 
therapeutic value in severely ill patients i»e„ patients in 
cardiogenic shock» Possible explanations of these findings 
were suggested»
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